Post-acne Erythema Successfully Treated with 595-nm Picosecond-domain Neodymium:Yttrium-aluminum-garnet Laser

Kim, Jae Hong; Choe, Sung Jay; Kim, Tae Kyun

doi:10.25289/ml.2020.9.1.84

Cited by 4 publications

(20 citation statements)

References 10 publications

Supporting

Mentioning

Contrasting

Order By: Relevance

“…In addition, another theory is that PAE is caused by exogenous stimuli such as topical agents. 16 In this study, we found that light and laser-based devices were the most frequently used treatments for PAE. Generally, pulsed-dye lasers, which are non-ablative lasers, were the most commonly used laser devices for PAE.…”

Section: Discussionmentioning

confidence: 80%

“…To half and each half randomly Received treatment with 577-nm HOPSL treatment (QuadroStar PRO ™ , Asclepion Laser Technologies) using the scanner handpiece, 1 mm spot size, 80% coverage, 12-15 J/cm 2 , 30 ms, 2 passes or no treatment Wen et al 11 A randomized split-face, investigatorblinded study 2020 16 Not reported III-V Each participants' face was divided to two sides. One side was treated with a 755 nm picosecond alexandrite laser with a fixed spot size of 6 mm, fluence of 0.71 J/cm 2 , pulse repetition of 5 Hz, and two to three passes were applied.…”

Section: Iii-v Patients Face Was Dividedmentioning

confidence: 99%

“…16 This wavelength is better absorbed in oxyhemoglobin than 532 nm but less wellabsorbed in melanin making it target a chromophore more distinctively. 16 In facial erythema, the target chromophore is hemoglobin. 12 In terms of comparing the cost-effectiveness, Nd:YAG lasers have a cooling system which increases the expenditure and contributes to a poorer ergonomic design.…”

Section: Light and Laser Therapymentioning

confidence: 99%

See 2 more Smart Citations

Post‐acne erythema treatment: A systematic review of the literature

Kalantari

Dadkhahfar

Etesami

2022

J of Cosmetic Dermatology

View full text Add to dashboard Cite

Post-acne erythema (PAE) is a common sequela of acne inflammation, and it refers to telangiectasia and erythematous lesions remaining after the acne treatment. Although some PAE lesions may improve over time, persisting PAE might be esthetically undesirable for patients. The efficacy of various treatment options for PAE has been investigated in many studies but there exists no gold standard treatment modality. In this study, we aimed to give a systematic literature review on various treatment options for PAE, the advantage of each modality, and compare their efficacy, safety, and feasibility. By using the selected keywords, we carried out a systematic search for articles published from the inception to 28 April 2021 in PubMed/Medline and Embase databases. Of the 5796 initially retrieved articles, 18 of them were fully eligible to be enrolled in our study. In this study, we found that light and laser-based devices were the most frequently used treatments for PAE. Generally, pulsed-dye lasers were the most commonly used laser devices for PAE. Neodymium:yttrium aluminum-garnet lasers were the second most commonly used modalities in treating PAE. Topical treatments such as oxymetazoline, tranexamic acid, and brimonidine tartrate are promising treatments in reducing PAE lesions. In our study, no severe side effects were found. In conclusion, both laser devices and topical agents seem to be effective for PAE lesions; however, further randomized clinical trials are needed in this field.

show abstract

Section: Discussionmentioning

confidence: 80%

Section: Iii-v Patients Face Was Dividedmentioning

confidence: 99%

Section: Light and Laser Therapymentioning

confidence: 99%

See 1 more Smart Citation

Post‐acne erythema treatment: A systematic review of the literature

Kalantari

Dadkhahfar

Etesami

2022

J of Cosmetic Dermatology

View full text Add to dashboard Cite

show abstract

“…Several vascular laser treatments were tried over the past few years in the treatment of PAE such as pulsed dye laser, 7 Low-Fluence 585 nm Q-Switched Nd:YAG Laser, 1 picosecond alexandrite laser, 8 577 nm pro-yellow laser 9 and with 595-nm Picosecond-domain ND-YAG Laser. 10 Also, other procedures such as intense pulsed light therapy 10 and fractional radiofrequency micro needling. 3 other lasers like 589/1319 laser system have proven good results in treatment of acne and post acne.…”

Section: Introductionmentioning

confidence: 99%

“…Several vascular laser treatments were tried over the past few years in the treatment of PAE such as pulsed dye laser, 7 Low‐Fluence 585 nm Q‐Switched Nd:YAG Laser, 1 picosecond alexandrite laser, 8 577 nm pro‐yellow laser 9 and with 595‐nm Picosecond‐domain ND‐YAG Laser 10 …”

Section: Introductionmentioning

confidence: 99%

A split face comparative study using a novel triple combination therapy for the treatment of persistent post acne erythema

Agamia

El‐Nagdy

Elariny

2022

Dermatologic Therapy

View full text Add to dashboard Cite

Persistent post acne erythema (PAE) is common cosmetically unacceptable and challenging sequelae of acne lesions. Tranexamic acid (TXA) is an antifibrinolytic agent that shows a positive effect on wound healing in several studies, and it showed benefits in treating skin diseases like melasma, rosacea erythema and ultraviolet induced pigmentations. Oxymetazoline (OXZ) is a synthetic, highly selective agonist for alpha 1A‐adrenoceptor. It is a potent vasoconstrictor. OXZ hydrochloride 1% cream was approved by the FDA in January 2017 as a topical treatment for persistent facial erythema in rosacea patients. Brimonidine tartrate (BMT) is highly selective α2 adrenergic receptor agonist, results in direct, potent vasoconstriction of small arterioles and veins. In 2013, brimonidine 0.33% gel was the first topical therapy to be FDA approved for the treatment of persistent facial erythema from rosacea. To evaluate the efficacy and safety of topical triple combination (TXA 5% + OXZ 1.5% + BMT 0.33%) in the treatment of PAE planned as split face comparative study. This study was conducted on 40 patients diagnosed with persistent PAE for at least 3 months, the right side of the face was treated with topical triple combination in liposomal base and was compared to the left side to which topical lipocream (placebo) was applied as a control. Our treatment plan lasted for 3 months. According to the investigator's global assessment of photographs and computerized analysis of erythema using image analysis software, topical triple combination applied on the right side of face was significantly effective in diminishing PAE when compared to topical placebo left side. Topical triple combination is a safe and cost‐effective treatment for PAE.

show abstract